WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 482
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 572

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'133  1'114  1'096  1'079  1'064  854  751  581 
Births 41  40  40  39  39  38  33  23 
Surviving infants 39  39  38  38  37  35  28  18 
Pop. less than 5 years 190  190  188  181  177  174  124  76 
Pop. less than 15 years 519  518  516  511  508  425  298  231 
Female 15-49 years 242  234  228  223  219  168  191  151 

Number of reported case

(Click for retrospective incidence data for Timor-Leste)
Diphtheria
Japanese encephalitis
Measles 16  763  50  10 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 11  10 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Timor-Leste)
Vaccine year result method % card seen                                                
BCG 2008  77  DHS   50  82  71  68  71  71 
DTP1 2008  75  DHS   50  86  82  69  75  76 
DTP3 2008  66  DHS   50  82  83  67  72  72 
HepB_BD         
HepB3 2008  66  DHS   50  82  83  67  72  72 
Hib3          82 
JapEnc         
MCV 2008  68  DHS   50  70  73  62  66  70 
MCV2         
PCV1         
PCV3         
Pol3 2008  56  DHS   50  82  83  66  72  78 
Rota1         
Rota_last         
Rubella1         
TT2plus 2004  60  EPI   26  37  39  38  33  39 
PAB         
VAD1          58  57  39  51  84 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Timor-Leste)
BCG 82  71  68  71  71 
DTP1 86  94  69  75  76 
DTP3 82  83  67  72  72 
HepB3 82  83  67  72  72 
HepB_BD
Hib3 82 
MCV 70  73  62  66  70 
MCV2
PAB 81  81  81  81  81 
PCV3
Pol3 82  83  66  72  78 
Rota_last

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 23
From 80 to 89% 38
From 50 to 79% 38
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth- 1 year; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2009-2013  2009-2013  2009-2013    2009-2013     
Nº of districts with microplans that include activities to raise immunization coverage number 13  10  13     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 62  54  15  23  46  46  31 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 15  15  15   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  Yes  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 76  26  100  100  100     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.